Blinatumomab-induced lineage switch of B-ALL with t(4:11)(q21;q23) KMT2A/AFF1 into an aggressive AML: pre- and post-switch phenotypic, cytogenetic and molecular analysis
Blood Cancer Journal 7, e607 (September 2017). doi:10.1038/bcj.2017.89
Authors: C L Haddox, A A Mangaonkar, D Chen, M Shi, R He, J L Oliveira, M R Litzow, A Al-Kali, W J Hogan & M A Elliott
from ! ORL Sfakianakis via paythelady.61 on Inoreader http://ift.tt/2xIgxSw
via IFTTT
Δεν υπάρχουν σχόλια:
Δημοσίευση σχολίου
Medicine by Alexandros G. Sfakianakis,Anapafseos 5 Agios Nikolaos 72100 Crete Greece,00302841026182,00306932607174,alsfakia@gmail.com,